Germany: Avatera Medical plans Frankfurt IPO
Sapinda-owned medical devices manufacturer Aventera is planning an IPO to raise less than €100m (US$112.3m) on the Frankfurt Stock exchange.
The Jena-based company was founded...
Australia: Infratil and Morrison to buy Qscan
New Zealand-based infrastructure company Infratil and Australian investment firm Morrison are to buy a majority stake in Qscan Radiology Clinics, the Queensland-focused, radiologist owned...
New Zealand: Oceania signs NZ$500m sustainability-linked loan
Residential care company, Oceania Healthcare, has signed a NZ$500m (US$311.9m) five-year Sustainability-Linked Loan (SLL) linked to three Key Performance Indicators (KPI) covering environmental and...
Israel: Nanox Imaging closes US$59m Series B funding ahead of IPO
Medical imaging technology company Nanox Imaging has completed US$59m Series B funding led by Foxconn as it gears up for a US$125m Nasdaq initial...
Denmark: Mads Møller Kristensen and DanCann Pharma parting ways
DanCann Pharma, a Danish biopharmaceutical company focussed on the development, manufacturing and commercialising of therapeutic cannabinoids, is parting ways with CFO Mads Møller Kristensen. He...
Saudi Arabia: MEFIC acquires 44% stake in MERAS Arabia Medical
Middle East Financial Investment has taken a 44% stake in in Meras Arabia Medical Holding Company.
MEFIC has acquired a 44% stake in Meras via...
Spain: EQT to acquire Igenomix from Charme Capital
Investment firm EQT is to acquire Spanish reproductive genetics company Igenomix from Charme Capital. Financial terms have not been disclosed.
“Igenomix is a global leader...
New Zealand: Healthscope to sell NZ pathology business for NZ$550m
Private hospital operator Healthscope is to sell its New Zealand pathology business to the NZ Super Fund and Ontario Teachers’ Pension Plan Board for...
Global: Early-stage healthcare funding slows for Thanksgiving holidays
Early-stage funding for healthcare companies was slow last week, possibly a reflection of the Thanksgiving holidays in the US.
Shanghai-based ophthalmic biotechnology company Eluminex Biosciences...
France: Icade prints debut benchmark
Icade Santé, the healthcare arm of French property group Icade, has printed a debut €500m benchmark bond.
Thanks to strong demand – it was oversubscribed...
©2023 All rights reserved LaingBuisson 
